Münch group describes coronavirus infection & potential therapies.
SARS-CoV-2 infection profile and therapeutic strategies.
Complementing conventional antibiotics: Frankfurt scientists reveal atomic details for one of Legionella’s enzymatic weapons and develop first inhibitor.
24 Jan 2023
Congratulations to @iDikic2 & Brenda Schulman @MPI_Biochem on being awarded the @LouisJeantetFDN Prize in Medicine… https://t.co/zZOuSkrgJc
09 Dec 2022
Congratulation to the @AnjaBremm lab! Exciting mechanistic insights into #autophagy regulation. Thanks to… https://t.co/Hdaaq1LCd5
30 Nov 2022
RT @ManuelKaulich: Join us for the next CGIM virtual seminar with @LukeGilbertSF - "Mapping genetic interactions with CRISPR functional gen…
17 Nov 2022
Exciting insights in complex I assembly: A new link with #cardiolipin remodeling is now published in… https://t.co/Vk7DSgoH4W
FOLLOW ON TWITTER